|

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

RECRUITINGPhase 1/2Sponsored by Antelope Surgical Solutions, Inc
Actively Recruiting
PhasePhase 1/2
SponsorAntelope Surgical Solutions, Inc
Started2026-07-01
Est. completion2026-10-30
Eligibility
Age18 Years – 90 Years
SexMALE
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT06906471

Summary

A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS

Eligibility

Age: 18 Years – 90 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* suspected prostate cancer warranting standard of care multi-core prostate biopsy

Exclusion Criteria:

* Patients receiving same-day therapeutic Lutetium-177 or Actinium-225 PSMA receptor radiation isotope therapy treatment
* Patients with pre-existing, impaired or abnormal hepatic function, renal function, cardiac function, and abnormal elevated temperature
* Patients with a creatinine clearance cutoff (CrCl) of \< 60 mL/min

Conditions4

CancerFluorescence ImagingProstate CancerProstate Cancer (Adenocarcinoma)

Interventions1

AS1986NS

Locations2 sites

Florida

1 site
HCA Florida Kendall Hospital
Miami, Florida, 33175
Shirin Razdan, MD305-468-3314srazdan@miamiroboticsurgery.com

New York

1 site
Icahn School of Medicine at Mount Sinai (ISMMS)
New York, New York, 10029
Sujit Nair, PhD212-241-6500sujit.nair@mountsinai.org

Find trials near these locations

Cancer trials in MiamiCancer trials in New YorkAll trials in FloridaAll trials in New York

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.